8 pending office actions • 3 art units • 3 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (62%) |
| No statute on record | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARSKY, JARED | 4 | 50.2% | +23.0% |
| MENDEZ, MANUEL A | 3 | 86.1% | +8.2% |
| NGUYEN, JOHN P | 1 | 44.5% | +41.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18306660 | METHODS OF ADMINISTERING DOFETILIDE | MENDEZ, MANUEL A | 43d |
| 18315790 | METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE | MENDEZ, MANUEL A | 62d |
| 18321220 | METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE | MENDEZ, MANUEL A | 68d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18324703 | METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL | BARSKY, JARED | 131d overdue |
| 18126561 | METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE | BARSKY, JARED | 125d overdue |
| 18417748 | METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING | BARSKY, JARED | 121d overdue |
| 17306490 | METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE | NGUYEN, JOHN P | 30d overdue |
| 17861226 | METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING | BARSKY, JARED | 29d |
| Art Unit | Apps |
|---|---|
| 1628 | 4 |
| 3783 | 3 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18417748 | METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING | BARSKY, JARED | 1628 | Other | Non-Final OA | 121d overdue | Pending | Jan 19, 2024 |
| 18324703 | METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL | BARSKY, JARED | 1628 | Other | Non-Final OA | 131d overdue | Pending | May 26, 2023 |
| 18321220 | METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE | MENDEZ, MANUEL A | 3783 | §103 | Non-Final OA | 68d | Pending | May 22, 2023 |
| 18315790 | METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE | MENDEZ, MANUEL A | 3783 | §103 | Non-Final OA | 62d | Pending | May 11, 2023 |
| 18306660 | METHODS OF ADMINISTERING DOFETILIDE | MENDEZ, MANUEL A | 3783 | §103 | Non-Final OA | 43d | Pending | Apr 25, 2023 |
| 18126561 | METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE | BARSKY, JARED | 1628 | Other | Final Rejection | 125d overdue | Pending | Mar 27, 2023 |
| 17861226 | METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING | BARSKY, JARED | 1628 | §103 | Final Rejection | 29d | Pending | Jul 10, 2022 |
| 17306490 | METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE | NGUYEN, JOHN P | 1619 | §103 | Final Rejection | 30d overdue | Pending | May 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial